发明授权
US07332592B2 Isolated recombinant bovine soluble CD14 polypeptide, rbosCD14
失效
分离的重组牛可溶性CD14多肽,rbosCD14
- 专利标题: Isolated recombinant bovine soluble CD14 polypeptide, rbosCD14
- 专利标题(中): 分离的重组牛可溶性CD14多肽,rbosCD14
-
申请号: US11144747申请日: 2005-06-03
-
公开(公告)号: US07332592B2公开(公告)日: 2008-02-19
- 发明人: Yan Wang , Dante S. Zarlenga , Max J. Paape
- 申请人: Yan Wang , Dante S. Zarlenga , Max J. Paape
- 申请人地址: US DC Washington
- 专利权人: The United States of America as represented by the Secretary of Agriculture
- 当前专利权人: The United States of America as represented by the Secretary of Agriculture
- 当前专利权人地址: US DC Washington
- 代理商 John Fado; Evelyn Rabin
- 主分类号: C07H21/02
- IPC分类号: C07H21/02 ; C07H21/04
摘要:
Studies in mice and humans indicate that membrane CD14 (mCD14) on the cell surface of monocytes, macrophages, and PMN mediates the activation of these cells by LPS. The soluble CD14 (sCD14) present in the circulation also binds to LPS and blocks LPS binding to mCD14. To determine the role of a recombinant bovine soluble CD14 polypeptide in cellular activation by LPS, a recombinant bovine soluble CD14 polypeptide, rbosCD14, was cloned and expressed in a baculovirus expression system. Results indicated that rbosCD14 inhibited the LPS-induced increase in CD18 expression and TNFα mRNA in vitro and reduced mortality in mice injected with LPS. Further, rbosCD14 sensitized mammary epithelial cells to low concentrations of LPS resulting in recruitment of white blood cells and prevention of LPS-induced infection.
公开/授权文献
信息查询